Global Human Plasma-derived Hyperimmune Product Market Research Report 2024(Status and Outlook)
Report Overview:
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The Global Human Plasma-derived Hyperimmune Product Market Size was estimated at USD 1983.59 million in 2023 and is projected to reach USD 2845.76 million by 2029, exhibiting a CAGR of 6.20% during the forecast period.
This report provides a deep insight into the global Human Plasma-derived Hyperimmune Product market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Plasma-derived Hyperimmune Product Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Plasma-derived Hyperimmune Product market in any manner.
Global Human Plasma-derived Hyperimmune Product Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Market Segmentation (by Type)
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Market Segmentation (by Application)
Government Institution
Private Sector
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Plasma-derived Hyperimmune Product Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The Global Human Plasma-derived Hyperimmune Product Market Size was estimated at USD 1983.59 million in 2023 and is projected to reach USD 2845.76 million by 2029, exhibiting a CAGR of 6.20% during the forecast period.
This report provides a deep insight into the global Human Plasma-derived Hyperimmune Product market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Plasma-derived Hyperimmune Product Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Plasma-derived Hyperimmune Product market in any manner.
Global Human Plasma-derived Hyperimmune Product Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Market Segmentation (by Type)
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Market Segmentation (by Application)
Government Institution
Private Sector
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Human Plasma-derived Hyperimmune Product Market
- Overview of the regional outlook of the Human Plasma-derived Hyperimmune Product Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Plasma-derived Hyperimmune Product Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Human Plasma-derived Hyperimmune Product
1.2 Key Market Segments
1.2.1 Human Plasma-derived Hyperimmune Product Segment by Type
1.2.2 Human Plasma-derived Hyperimmune Product Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Plasma-derived Hyperimmune Product Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Plasma-derived Hyperimmune Product Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Plasma-derived Hyperimmune Product Sales by Manufacturers (2019-2024)
3.2 Global Human Plasma-derived Hyperimmune Product Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Plasma-derived Hyperimmune Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Plasma-derived Hyperimmune Product Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Plasma-derived Hyperimmune Product Sales Sites, Area Served, Product Type
3.6 Human Plasma-derived Hyperimmune Product Market Competitive Situation and Trends
3.6.1 Human Plasma-derived Hyperimmune Product Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Plasma-derived Hyperimmune Product Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT INDUSTRY CHAIN ANALYSIS
4.1 Human Plasma-derived Hyperimmune Product Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Plasma-derived Hyperimmune Product Sales Market Share by Type (2019-2024)
6.3 Global Human Plasma-derived Hyperimmune Product Market Size Market Share by Type (2019-2024)
6.4 Global Human Plasma-derived Hyperimmune Product Price by Type (2019-2024)
7 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Plasma-derived Hyperimmune Product Market Sales by Application (2019-2024)
7.3 Global Human Plasma-derived Hyperimmune Product Market Size (M USD) by Application (2019-2024)
7.4 Global Human Plasma-derived Hyperimmune Product Sales Growth Rate by Application (2019-2024)
8 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET SEGMENTATION BY REGION
8.1 Global Human Plasma-derived Hyperimmune Product Sales by Region
8.1.1 Global Human Plasma-derived Hyperimmune Product Sales by Region
8.1.2 Global Human Plasma-derived Hyperimmune Product Sales Market Share by Region
8.2 North America
8.2.1 North America Human Plasma-derived Hyperimmune Product Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Plasma-derived Hyperimmune Product Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Plasma-derived Hyperimmune Product Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Plasma-derived Hyperimmune Product Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Plasma-derived Hyperimmune Product Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL Behring
9.1.1 CSL Behring Human Plasma-derived Hyperimmune Product Basic Information
9.1.2 CSL Behring Human Plasma-derived Hyperimmune Product Product Overview
9.1.3 CSL Behring Human Plasma-derived Hyperimmune Product Product Market Performance
9.1.4 CSL Behring Business Overview
9.1.5 CSL Behring Human Plasma-derived Hyperimmune Product SWOT Analysis
9.1.6 CSL Behring Recent Developments
9.2 Grifols
9.2.1 Grifols Human Plasma-derived Hyperimmune Product Basic Information
9.2.2 Grifols Human Plasma-derived Hyperimmune Product Product Overview
9.2.3 Grifols Human Plasma-derived Hyperimmune Product Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Human Plasma-derived Hyperimmune Product SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 Biotest
9.3.1 Biotest Human Plasma-derived Hyperimmune Product Basic Information
9.3.2 Biotest Human Plasma-derived Hyperimmune Product Product Overview
9.3.3 Biotest Human Plasma-derived Hyperimmune Product Product Market Performance
9.3.4 Biotest Human Plasma-derived Hyperimmune Product SWOT Analysis
9.3.5 Biotest Business Overview
9.3.6 Biotest Recent Developments
9.4 Kedrion
9.4.1 Kedrion Human Plasma-derived Hyperimmune Product Basic Information
9.4.2 Kedrion Human Plasma-derived Hyperimmune Product Product Overview
9.4.3 Kedrion Human Plasma-derived Hyperimmune Product Product Market Performance
9.4.4 Kedrion Business Overview
9.4.5 Kedrion Recent Developments
9.5 CBPO
9.5.1 CBPO Human Plasma-derived Hyperimmune Product Basic Information
9.5.2 CBPO Human Plasma-derived Hyperimmune Product Product Overview
9.5.3 CBPO Human Plasma-derived Hyperimmune Product Product Market Performance
9.5.4 CBPO Business Overview
9.5.5 CBPO Recent Developments
9.6 Emergent (Cangene)
9.6.1 Emergent (Cangene) Human Plasma-derived Hyperimmune Product Basic Information
9.6.2 Emergent (Cangene) Human Plasma-derived Hyperimmune Product Product Overview
9.6.3 Emergent (Cangene) Human Plasma-derived Hyperimmune Product Product Market Performance
9.6.4 Emergent (Cangene) Business Overview
9.6.5 Emergent (Cangene) Recent Developments
9.7 Kamada
9.7.1 Kamada Human Plasma-derived Hyperimmune Product Basic Information
9.7.2 Kamada Human Plasma-derived Hyperimmune Product Product Overview
9.7.3 Kamada Human Plasma-derived Hyperimmune Product Product Market Performance
9.7.4 Kamada Business Overview
9.7.5 Kamada Recent Developments
9.8 CNBG
9.8.1 CNBG Human Plasma-derived Hyperimmune Product Basic Information
9.8.2 CNBG Human Plasma-derived Hyperimmune Product Product Overview
9.8.3 CNBG Human Plasma-derived Hyperimmune Product Product Market Performance
9.8.4 CNBG Business Overview
9.8.5 CNBG Recent Developments
9.9 Hualan Bio
9.9.1 Hualan Bio Human Plasma-derived Hyperimmune Product Basic Information
9.9.2 Hualan Bio Human Plasma-derived Hyperimmune Product Product Overview
9.9.3 Hualan Bio Human Plasma-derived Hyperimmune Product Product Market Performance
9.9.4 Hualan Bio Business Overview
9.9.5 Hualan Bio Recent Developments
9.10 Shanghai RAAS
9.10.1 Shanghai RAAS Human Plasma-derived Hyperimmune Product Basic Information
9.10.2 Shanghai RAAS Human Plasma-derived Hyperimmune Product Product Overview
9.10.3 Shanghai RAAS Human Plasma-derived Hyperimmune Product Product Market Performance
9.10.4 Shanghai RAAS Business Overview
9.10.5 Shanghai RAAS Recent Developments
9.11 Sichuan Yuanda Shuyang
9.11.1 Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Basic Information
9.11.2 Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Product Overview
9.11.3 Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Product Market Performance
9.11.4 Sichuan Yuanda Shuyang Business Overview
9.11.5 Sichuan Yuanda Shuyang Recent Developments
9.12 ADMA Biologics
9.12.1 ADMA Biologics Human Plasma-derived Hyperimmune Product Basic Information
9.12.2 ADMA Biologics Human Plasma-derived Hyperimmune Product Product Overview
9.12.3 ADMA Biologics Human Plasma-derived Hyperimmune Product Product Market Performance
9.12.4 ADMA Biologics Business Overview
9.12.5 ADMA Biologics Recent Developments
10 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET FORECAST BY REGION
10.1 Global Human Plasma-derived Hyperimmune Product Market Size Forecast
10.2 Global Human Plasma-derived Hyperimmune Product Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Plasma-derived Hyperimmune Product Market Size Forecast by Country
10.2.3 Asia Pacific Human Plasma-derived Hyperimmune Product Market Size Forecast by Region
10.2.4 South America Human Plasma-derived Hyperimmune Product Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Plasma-derived Hyperimmune Product by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Human Plasma-derived Hyperimmune Product Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Plasma-derived Hyperimmune Product by Type (2025-2030)
11.1.2 Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Plasma-derived Hyperimmune Product by Type (2025-2030)
11.2 Global Human Plasma-derived Hyperimmune Product Market Forecast by Application (2025-2030)
11.2.1 Global Human Plasma-derived Hyperimmune Product Sales (Kilotons) Forecast by Application
11.2.2 Global Human Plasma-derived Hyperimmune Product Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Human Plasma-derived Hyperimmune Product
1.2 Key Market Segments
1.2.1 Human Plasma-derived Hyperimmune Product Segment by Type
1.2.2 Human Plasma-derived Hyperimmune Product Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Plasma-derived Hyperimmune Product Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Plasma-derived Hyperimmune Product Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Plasma-derived Hyperimmune Product Sales by Manufacturers (2019-2024)
3.2 Global Human Plasma-derived Hyperimmune Product Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Plasma-derived Hyperimmune Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Plasma-derived Hyperimmune Product Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Plasma-derived Hyperimmune Product Sales Sites, Area Served, Product Type
3.6 Human Plasma-derived Hyperimmune Product Market Competitive Situation and Trends
3.6.1 Human Plasma-derived Hyperimmune Product Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Plasma-derived Hyperimmune Product Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT INDUSTRY CHAIN ANALYSIS
4.1 Human Plasma-derived Hyperimmune Product Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Plasma-derived Hyperimmune Product Sales Market Share by Type (2019-2024)
6.3 Global Human Plasma-derived Hyperimmune Product Market Size Market Share by Type (2019-2024)
6.4 Global Human Plasma-derived Hyperimmune Product Price by Type (2019-2024)
7 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Plasma-derived Hyperimmune Product Market Sales by Application (2019-2024)
7.3 Global Human Plasma-derived Hyperimmune Product Market Size (M USD) by Application (2019-2024)
7.4 Global Human Plasma-derived Hyperimmune Product Sales Growth Rate by Application (2019-2024)
8 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET SEGMENTATION BY REGION
8.1 Global Human Plasma-derived Hyperimmune Product Sales by Region
8.1.1 Global Human Plasma-derived Hyperimmune Product Sales by Region
8.1.2 Global Human Plasma-derived Hyperimmune Product Sales Market Share by Region
8.2 North America
8.2.1 North America Human Plasma-derived Hyperimmune Product Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Plasma-derived Hyperimmune Product Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Plasma-derived Hyperimmune Product Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Plasma-derived Hyperimmune Product Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Plasma-derived Hyperimmune Product Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL Behring
9.1.1 CSL Behring Human Plasma-derived Hyperimmune Product Basic Information
9.1.2 CSL Behring Human Plasma-derived Hyperimmune Product Product Overview
9.1.3 CSL Behring Human Plasma-derived Hyperimmune Product Product Market Performance
9.1.4 CSL Behring Business Overview
9.1.5 CSL Behring Human Plasma-derived Hyperimmune Product SWOT Analysis
9.1.6 CSL Behring Recent Developments
9.2 Grifols
9.2.1 Grifols Human Plasma-derived Hyperimmune Product Basic Information
9.2.2 Grifols Human Plasma-derived Hyperimmune Product Product Overview
9.2.3 Grifols Human Plasma-derived Hyperimmune Product Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Human Plasma-derived Hyperimmune Product SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 Biotest
9.3.1 Biotest Human Plasma-derived Hyperimmune Product Basic Information
9.3.2 Biotest Human Plasma-derived Hyperimmune Product Product Overview
9.3.3 Biotest Human Plasma-derived Hyperimmune Product Product Market Performance
9.3.4 Biotest Human Plasma-derived Hyperimmune Product SWOT Analysis
9.3.5 Biotest Business Overview
9.3.6 Biotest Recent Developments
9.4 Kedrion
9.4.1 Kedrion Human Plasma-derived Hyperimmune Product Basic Information
9.4.2 Kedrion Human Plasma-derived Hyperimmune Product Product Overview
9.4.3 Kedrion Human Plasma-derived Hyperimmune Product Product Market Performance
9.4.4 Kedrion Business Overview
9.4.5 Kedrion Recent Developments
9.5 CBPO
9.5.1 CBPO Human Plasma-derived Hyperimmune Product Basic Information
9.5.2 CBPO Human Plasma-derived Hyperimmune Product Product Overview
9.5.3 CBPO Human Plasma-derived Hyperimmune Product Product Market Performance
9.5.4 CBPO Business Overview
9.5.5 CBPO Recent Developments
9.6 Emergent (Cangene)
9.6.1 Emergent (Cangene) Human Plasma-derived Hyperimmune Product Basic Information
9.6.2 Emergent (Cangene) Human Plasma-derived Hyperimmune Product Product Overview
9.6.3 Emergent (Cangene) Human Plasma-derived Hyperimmune Product Product Market Performance
9.6.4 Emergent (Cangene) Business Overview
9.6.5 Emergent (Cangene) Recent Developments
9.7 Kamada
9.7.1 Kamada Human Plasma-derived Hyperimmune Product Basic Information
9.7.2 Kamada Human Plasma-derived Hyperimmune Product Product Overview
9.7.3 Kamada Human Plasma-derived Hyperimmune Product Product Market Performance
9.7.4 Kamada Business Overview
9.7.5 Kamada Recent Developments
9.8 CNBG
9.8.1 CNBG Human Plasma-derived Hyperimmune Product Basic Information
9.8.2 CNBG Human Plasma-derived Hyperimmune Product Product Overview
9.8.3 CNBG Human Plasma-derived Hyperimmune Product Product Market Performance
9.8.4 CNBG Business Overview
9.8.5 CNBG Recent Developments
9.9 Hualan Bio
9.9.1 Hualan Bio Human Plasma-derived Hyperimmune Product Basic Information
9.9.2 Hualan Bio Human Plasma-derived Hyperimmune Product Product Overview
9.9.3 Hualan Bio Human Plasma-derived Hyperimmune Product Product Market Performance
9.9.4 Hualan Bio Business Overview
9.9.5 Hualan Bio Recent Developments
9.10 Shanghai RAAS
9.10.1 Shanghai RAAS Human Plasma-derived Hyperimmune Product Basic Information
9.10.2 Shanghai RAAS Human Plasma-derived Hyperimmune Product Product Overview
9.10.3 Shanghai RAAS Human Plasma-derived Hyperimmune Product Product Market Performance
9.10.4 Shanghai RAAS Business Overview
9.10.5 Shanghai RAAS Recent Developments
9.11 Sichuan Yuanda Shuyang
9.11.1 Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Basic Information
9.11.2 Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Product Overview
9.11.3 Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Product Market Performance
9.11.4 Sichuan Yuanda Shuyang Business Overview
9.11.5 Sichuan Yuanda Shuyang Recent Developments
9.12 ADMA Biologics
9.12.1 ADMA Biologics Human Plasma-derived Hyperimmune Product Basic Information
9.12.2 ADMA Biologics Human Plasma-derived Hyperimmune Product Product Overview
9.12.3 ADMA Biologics Human Plasma-derived Hyperimmune Product Product Market Performance
9.12.4 ADMA Biologics Business Overview
9.12.5 ADMA Biologics Recent Developments
10 HUMAN PLASMA-DERIVED HYPERIMMUNE PRODUCT MARKET FORECAST BY REGION
10.1 Global Human Plasma-derived Hyperimmune Product Market Size Forecast
10.2 Global Human Plasma-derived Hyperimmune Product Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Plasma-derived Hyperimmune Product Market Size Forecast by Country
10.2.3 Asia Pacific Human Plasma-derived Hyperimmune Product Market Size Forecast by Region
10.2.4 South America Human Plasma-derived Hyperimmune Product Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Plasma-derived Hyperimmune Product by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Human Plasma-derived Hyperimmune Product Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Plasma-derived Hyperimmune Product by Type (2025-2030)
11.1.2 Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Plasma-derived Hyperimmune Product by Type (2025-2030)
11.2 Global Human Plasma-derived Hyperimmune Product Market Forecast by Application (2025-2030)
11.2.1 Global Human Plasma-derived Hyperimmune Product Sales (Kilotons) Forecast by Application
11.2.2 Global Human Plasma-derived Hyperimmune Product Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Plasma-derived Hyperimmune Product Market Size Comparison by Region (M USD)
Table 5. Global Human Plasma-derived Hyperimmune Product Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Plasma-derived Hyperimmune Product Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Plasma-derived Hyperimmune Product Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Plasma-derived Hyperimmune Product as of 2022)
Table 10. Global Market Human Plasma-derived Hyperimmune Product Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Plasma-derived Hyperimmune Product Sales Sites and Area Served
Table 12. Manufacturers Human Plasma-derived Hyperimmune Product Product Type
Table 13. Global Human Plasma-derived Hyperimmune Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Plasma-derived Hyperimmune Product
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Plasma-derived Hyperimmune Product Market Challenges
Table 22. Global Human Plasma-derived Hyperimmune Product Sales by Type (Kilotons)
Table 23. Global Human Plasma-derived Hyperimmune Product Market Size by Type (M USD)
Table 24. Global Human Plasma-derived Hyperimmune Product Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Type (2019-2024)
Table 26. Global Human Plasma-derived Hyperimmune Product Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Plasma-derived Hyperimmune Product Market Size Share by Type (2019-2024)
Table 28. Global Human Plasma-derived Hyperimmune Product Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Plasma-derived Hyperimmune Product Sales (Kilotons) by Application
Table 30. Global Human Plasma-derived Hyperimmune Product Market Size by Application
Table 31. Global Human Plasma-derived Hyperimmune Product Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Application (2019-2024)
Table 33. Global Human Plasma-derived Hyperimmune Product Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Plasma-derived Hyperimmune Product Market Share by Application (2019-2024)
Table 35. Global Human Plasma-derived Hyperimmune Product Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Plasma-derived Hyperimmune Product Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Region (2019-2024)
Table 38. North America Human Plasma-derived Hyperimmune Product Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Plasma-derived Hyperimmune Product Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Plasma-derived Hyperimmune Product Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Plasma-derived Hyperimmune Product Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Plasma-derived Hyperimmune Product Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Behring Human Plasma-derived Hyperimmune Product Basic Information
Table 44. CSL Behring Human Plasma-derived Hyperimmune Product Product Overview
Table 45. CSL Behring Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Behring Business Overview
Table 47. CSL Behring Human Plasma-derived Hyperimmune Product SWOT Analysis
Table 48. CSL Behring Recent Developments
Table 49. Grifols Human Plasma-derived Hyperimmune Product Basic Information
Table 50. Grifols Human Plasma-derived Hyperimmune Product Product Overview
Table 51. Grifols Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Grifols Business Overview
Table 53. Grifols Human Plasma-derived Hyperimmune Product SWOT Analysis
Table 54. Grifols Recent Developments
Table 55. Biotest Human Plasma-derived Hyperimmune Product Basic Information
Table 56. Biotest Human Plasma-derived Hyperimmune Product Product Overview
Table 57. Biotest Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Biotest Human Plasma-derived Hyperimmune Product SWOT Analysis
Table 59. Biotest Business Overview
Table 60. Biotest Recent Developments
Table 61. Kedrion Human Plasma-derived Hyperimmune Product Basic Information
Table 62. Kedrion Human Plasma-derived Hyperimmune Product Product Overview
Table 63. Kedrion Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Kedrion Business Overview
Table 65. Kedrion Recent Developments
Table 66. CBPO Human Plasma-derived Hyperimmune Product Basic Information
Table 67. CBPO Human Plasma-derived Hyperimmune Product Product Overview
Table 68. CBPO Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. CBPO Business Overview
Table 70. CBPO Recent Developments
Table 71. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Basic Information
Table 72. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Product Overview
Table 73. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Emergent (Cangene) Business Overview
Table 75. Emergent (Cangene) Recent Developments
Table 76. Kamada Human Plasma-derived Hyperimmune Product Basic Information
Table 77. Kamada Human Plasma-derived Hyperimmune Product Product Overview
Table 78. Kamada Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Kamada Business Overview
Table 80. Kamada Recent Developments
Table 81. CNBG Human Plasma-derived Hyperimmune Product Basic Information
Table 82. CNBG Human Plasma-derived Hyperimmune Product Product Overview
Table 83. CNBG Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CNBG Business Overview
Table 85. CNBG Recent Developments
Table 86. Hualan Bio Human Plasma-derived Hyperimmune Product Basic Information
Table 87. Hualan Bio Human Plasma-derived Hyperimmune Product Product Overview
Table 88. Hualan Bio Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Hualan Bio Business Overview
Table 90. Hualan Bio Recent Developments
Table 91. Shanghai RAAS Human Plasma-derived Hyperimmune Product Basic Information
Table 92. Shanghai RAAS Human Plasma-derived Hyperimmune Product Product Overview
Table 93. Shanghai RAAS Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Shanghai RAAS Business Overview
Table 95. Shanghai RAAS Recent Developments
Table 96. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Basic Information
Table 97. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Product Overview
Table 98. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Sichuan Yuanda Shuyang Business Overview
Table 100. Sichuan Yuanda Shuyang Recent Developments
Table 101. ADMA Biologics Human Plasma-derived Hyperimmune Product Basic Information
Table 102. ADMA Biologics Human Plasma-derived Hyperimmune Product Product Overview
Table 103. ADMA Biologics Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. ADMA Biologics Business Overview
Table 105. ADMA Biologics Recent Developments
Table 106. Global Human Plasma-derived Hyperimmune Product Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Human Plasma-derived Hyperimmune Product Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Human Plasma-derived Hyperimmune Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Human Plasma-derived Hyperimmune Product Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Human Plasma-derived Hyperimmune Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Human Plasma-derived Hyperimmune Product Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Human Plasma-derived Hyperimmune Product Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Human Plasma-derived Hyperimmune Product Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Human Plasma-derived Hyperimmune Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Human Plasma-derived Hyperimmune Product Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Human Plasma-derived Hyperimmune Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Human Plasma-derived Hyperimmune Product Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Human Plasma-derived Hyperimmune Product Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Human Plasma-derived Hyperimmune Product Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Plasma-derived Hyperimmune Product Market Size Comparison by Region (M USD)
Table 5. Global Human Plasma-derived Hyperimmune Product Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Plasma-derived Hyperimmune Product Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Plasma-derived Hyperimmune Product Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Plasma-derived Hyperimmune Product as of 2022)
Table 10. Global Market Human Plasma-derived Hyperimmune Product Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Plasma-derived Hyperimmune Product Sales Sites and Area Served
Table 12. Manufacturers Human Plasma-derived Hyperimmune Product Product Type
Table 13. Global Human Plasma-derived Hyperimmune Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Plasma-derived Hyperimmune Product
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Plasma-derived Hyperimmune Product Market Challenges
Table 22. Global Human Plasma-derived Hyperimmune Product Sales by Type (Kilotons)
Table 23. Global Human Plasma-derived Hyperimmune Product Market Size by Type (M USD)
Table 24. Global Human Plasma-derived Hyperimmune Product Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Type (2019-2024)
Table 26. Global Human Plasma-derived Hyperimmune Product Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Plasma-derived Hyperimmune Product Market Size Share by Type (2019-2024)
Table 28. Global Human Plasma-derived Hyperimmune Product Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Plasma-derived Hyperimmune Product Sales (Kilotons) by Application
Table 30. Global Human Plasma-derived Hyperimmune Product Market Size by Application
Table 31. Global Human Plasma-derived Hyperimmune Product Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Application (2019-2024)
Table 33. Global Human Plasma-derived Hyperimmune Product Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Plasma-derived Hyperimmune Product Market Share by Application (2019-2024)
Table 35. Global Human Plasma-derived Hyperimmune Product Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Plasma-derived Hyperimmune Product Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Region (2019-2024)
Table 38. North America Human Plasma-derived Hyperimmune Product Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Plasma-derived Hyperimmune Product Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Plasma-derived Hyperimmune Product Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Plasma-derived Hyperimmune Product Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Plasma-derived Hyperimmune Product Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Behring Human Plasma-derived Hyperimmune Product Basic Information
Table 44. CSL Behring Human Plasma-derived Hyperimmune Product Product Overview
Table 45. CSL Behring Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Behring Business Overview
Table 47. CSL Behring Human Plasma-derived Hyperimmune Product SWOT Analysis
Table 48. CSL Behring Recent Developments
Table 49. Grifols Human Plasma-derived Hyperimmune Product Basic Information
Table 50. Grifols Human Plasma-derived Hyperimmune Product Product Overview
Table 51. Grifols Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Grifols Business Overview
Table 53. Grifols Human Plasma-derived Hyperimmune Product SWOT Analysis
Table 54. Grifols Recent Developments
Table 55. Biotest Human Plasma-derived Hyperimmune Product Basic Information
Table 56. Biotest Human Plasma-derived Hyperimmune Product Product Overview
Table 57. Biotest Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Biotest Human Plasma-derived Hyperimmune Product SWOT Analysis
Table 59. Biotest Business Overview
Table 60. Biotest Recent Developments
Table 61. Kedrion Human Plasma-derived Hyperimmune Product Basic Information
Table 62. Kedrion Human Plasma-derived Hyperimmune Product Product Overview
Table 63. Kedrion Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Kedrion Business Overview
Table 65. Kedrion Recent Developments
Table 66. CBPO Human Plasma-derived Hyperimmune Product Basic Information
Table 67. CBPO Human Plasma-derived Hyperimmune Product Product Overview
Table 68. CBPO Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. CBPO Business Overview
Table 70. CBPO Recent Developments
Table 71. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Basic Information
Table 72. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Product Overview
Table 73. Emergent (Cangene) Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Emergent (Cangene) Business Overview
Table 75. Emergent (Cangene) Recent Developments
Table 76. Kamada Human Plasma-derived Hyperimmune Product Basic Information
Table 77. Kamada Human Plasma-derived Hyperimmune Product Product Overview
Table 78. Kamada Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Kamada Business Overview
Table 80. Kamada Recent Developments
Table 81. CNBG Human Plasma-derived Hyperimmune Product Basic Information
Table 82. CNBG Human Plasma-derived Hyperimmune Product Product Overview
Table 83. CNBG Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CNBG Business Overview
Table 85. CNBG Recent Developments
Table 86. Hualan Bio Human Plasma-derived Hyperimmune Product Basic Information
Table 87. Hualan Bio Human Plasma-derived Hyperimmune Product Product Overview
Table 88. Hualan Bio Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Hualan Bio Business Overview
Table 90. Hualan Bio Recent Developments
Table 91. Shanghai RAAS Human Plasma-derived Hyperimmune Product Basic Information
Table 92. Shanghai RAAS Human Plasma-derived Hyperimmune Product Product Overview
Table 93. Shanghai RAAS Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Shanghai RAAS Business Overview
Table 95. Shanghai RAAS Recent Developments
Table 96. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Basic Information
Table 97. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Product Overview
Table 98. Sichuan Yuanda Shuyang Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Sichuan Yuanda Shuyang Business Overview
Table 100. Sichuan Yuanda Shuyang Recent Developments
Table 101. ADMA Biologics Human Plasma-derived Hyperimmune Product Basic Information
Table 102. ADMA Biologics Human Plasma-derived Hyperimmune Product Product Overview
Table 103. ADMA Biologics Human Plasma-derived Hyperimmune Product Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. ADMA Biologics Business Overview
Table 105. ADMA Biologics Recent Developments
Table 106. Global Human Plasma-derived Hyperimmune Product Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Human Plasma-derived Hyperimmune Product Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Human Plasma-derived Hyperimmune Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Human Plasma-derived Hyperimmune Product Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Human Plasma-derived Hyperimmune Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Human Plasma-derived Hyperimmune Product Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Human Plasma-derived Hyperimmune Product Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Human Plasma-derived Hyperimmune Product Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Human Plasma-derived Hyperimmune Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Human Plasma-derived Hyperimmune Product Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Human Plasma-derived Hyperimmune Product Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Human Plasma-derived Hyperimmune Product Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Human Plasma-derived Hyperimmune Product Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Human Plasma-derived Hyperimmune Product Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Human Plasma-derived Hyperimmune Product
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Plasma-derived Hyperimmune Product Market Size (M USD), 2019-2030
Figure 5. Global Human Plasma-derived Hyperimmune Product Market Size (M USD) (2019-2030)
Figure 6. Global Human Plasma-derived Hyperimmune Product Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Plasma-derived Hyperimmune Product Market Size by Country (M USD)
Figure 11. Human Plasma-derived Hyperimmune Product Sales Share by Manufacturers in 2023
Figure 12. Global Human Plasma-derived Hyperimmune Product Revenue Share by Manufacturers in 2023
Figure 13. Human Plasma-derived Hyperimmune Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Plasma-derived Hyperimmune Product Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Plasma-derived Hyperimmune Product Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Plasma-derived Hyperimmune Product Market Share by Type
Figure 18. Sales Market Share of Human Plasma-derived Hyperimmune Product by Type (2019-2024)
Figure 19. Sales Market Share of Human Plasma-derived Hyperimmune Product by Type in 2023
Figure 20. Market Size Share of Human Plasma-derived Hyperimmune Product by Type (2019-2024)
Figure 21. Market Size Market Share of Human Plasma-derived Hyperimmune Product by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Plasma-derived Hyperimmune Product Market Share by Application
Figure 24. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Application (2019-2024)
Figure 25. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Application in 2023
Figure 26. Global Human Plasma-derived Hyperimmune Product Market Share by Application (2019-2024)
Figure 27. Global Human Plasma-derived Hyperimmune Product Market Share by Application in 2023
Figure 28. Global Human Plasma-derived Hyperimmune Product Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Region (2019-2024)
Figure 30. North America Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Plasma-derived Hyperimmune Product Sales Market Share by Country in 2023
Figure 32. U.S. Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Plasma-derived Hyperimmune Product Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Plasma-derived Hyperimmune Product Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Plasma-derived Hyperimmune Product Sales Market Share by Country in 2023
Figure 37. Germany Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Plasma-derived Hyperimmune Product Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Plasma-derived Hyperimmune Product Sales Market Share by Region in 2023
Figure 44. China Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Plasma-derived Hyperimmune Product Sales and Growth Rate (Kilotons)
Figure 50. South America Human Plasma-derived Hyperimmune Product Sales Market Share by Country in 2023
Figure 51. Brazil Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Plasma-derived Hyperimmune Product Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Plasma-derived Hyperimmune Product Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Plasma-derived Hyperimmune Product Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Plasma-derived Hyperimmune Product Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Plasma-derived Hyperimmune Product Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Plasma-derived Hyperimmune Product Sales Forecast by Application (2025-2030)
Figure 66. Global Human Plasma-derived Hyperimmune Product Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Human Plasma-derived Hyperimmune Product
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Plasma-derived Hyperimmune Product Market Size (M USD), 2019-2030
Figure 5. Global Human Plasma-derived Hyperimmune Product Market Size (M USD) (2019-2030)
Figure 6. Global Human Plasma-derived Hyperimmune Product Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Plasma-derived Hyperimmune Product Market Size by Country (M USD)
Figure 11. Human Plasma-derived Hyperimmune Product Sales Share by Manufacturers in 2023
Figure 12. Global Human Plasma-derived Hyperimmune Product Revenue Share by Manufacturers in 2023
Figure 13. Human Plasma-derived Hyperimmune Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Plasma-derived Hyperimmune Product Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Plasma-derived Hyperimmune Product Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Plasma-derived Hyperimmune Product Market Share by Type
Figure 18. Sales Market Share of Human Plasma-derived Hyperimmune Product by Type (2019-2024)
Figure 19. Sales Market Share of Human Plasma-derived Hyperimmune Product by Type in 2023
Figure 20. Market Size Share of Human Plasma-derived Hyperimmune Product by Type (2019-2024)
Figure 21. Market Size Market Share of Human Plasma-derived Hyperimmune Product by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Plasma-derived Hyperimmune Product Market Share by Application
Figure 24. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Application (2019-2024)
Figure 25. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Application in 2023
Figure 26. Global Human Plasma-derived Hyperimmune Product Market Share by Application (2019-2024)
Figure 27. Global Human Plasma-derived Hyperimmune Product Market Share by Application in 2023
Figure 28. Global Human Plasma-derived Hyperimmune Product Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Plasma-derived Hyperimmune Product Sales Market Share by Region (2019-2024)
Figure 30. North America Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Plasma-derived Hyperimmune Product Sales Market Share by Country in 2023
Figure 32. U.S. Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Plasma-derived Hyperimmune Product Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Plasma-derived Hyperimmune Product Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Plasma-derived Hyperimmune Product Sales Market Share by Country in 2023
Figure 37. Germany Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Plasma-derived Hyperimmune Product Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Plasma-derived Hyperimmune Product Sales Market Share by Region in 2023
Figure 44. China Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Plasma-derived Hyperimmune Product Sales and Growth Rate (Kilotons)
Figure 50. South America Human Plasma-derived Hyperimmune Product Sales Market Share by Country in 2023
Figure 51. Brazil Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Plasma-derived Hyperimmune Product Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Plasma-derived Hyperimmune Product Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Plasma-derived Hyperimmune Product Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Plasma-derived Hyperimmune Product Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Plasma-derived Hyperimmune Product Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Plasma-derived Hyperimmune Product Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Plasma-derived Hyperimmune Product Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Plasma-derived Hyperimmune Product Sales Forecast by Application (2025-2030)
Figure 66. Global Human Plasma-derived Hyperimmune Product Market Share Forecast by Application (2025-2030)
